Announced
Synopsis
Sarvapriya Healthcare Solutions, a holding company, agreed to acquire a 42.36% stake in Dalmia Bharat Refractories, a refractories manufacturer, from Dalmia Bharat Group, a cement group, for $97m. “In line with its strategy to exit non-core business/investment and pursuant to the approval granted by its Board of Directors in its meeting held on March 25, 2023, Dalmia Cement (Bharat), a material wholly owned subsidiary of the Company, has entered into a binding agreement to sell its entire investment of 18m equity Shares of Rs. 10 each (42.36% of share capital) of Dalmia Bharat Refractories Limited (DBRL), an associate company, at a consideration of Rs. 800 cr. to M/s Sarvapriya Healthcare Solutions Private Limited (Sarvapriya), a promoter group Company.” Dalmia Bharat.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.